Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- Check7 days agoChange DetectedGlossary is now shown by default. Added metadata fields include Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed are the previously displayed (Estimated) indicators and Revision: v3.3.4.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, a minor update with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedLocations section updated with new site listings across multiple states and Ontario. Page revision updated to v3.3.3.SummaryDifference2%

- Check50 days agoChange DetectedThe update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)'. This is a minor textual adjustment to the update information on the study details page.SummaryDifference0.0%

- Check57 days agoChange DetectedNew 'Last Update Posted' dates were added (2025-12-08 and 2025-11-22), and the previously listed 'Last Update Posted (Estimated)' entries (2025-11-06 and 2025-11-19) were removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed, and a new revision tag (v3.3.2, 2025-11-19) replaces the previous note and revision (v3.2.0, 2025-10-24).SummaryDifference0.2%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.